Non-invasive urine based tests for the detection of bladder cancer

Journal of Clinical Pathology

Volumn 65, Issue 11, 2012, Pages 970-975

  Wadhwa, Neha ^a   Jatawa, Suresh Kumar ^a   Tiwari, Archana ^a  

^a UNIVERSITY INSTITUTE OF TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; BLADDER CANCER SPECIFIC NUCLEAR MATRIX PROTEIN 1; BLADDER CANCER SPECIFIC NUCLEAR MATRIX PROTEIN 4; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; COMPLEMENT FACTOR H; CYTOKERATIN; DD23 MONOCLONAL ANTIBODY; FIBROBLAST GROWTH FACTOR RECEPTOR 3; HYALURONIC ACID; HYALURONIDASE; MICRORNA; MICROSATELLITE DNA; MONOCLONAL ANTIBODY; NUCLEAR MATRIX PROTEIN 22; SIALYL LEWIS X ANTIGEN; SURVIVIN; TELOMERASE; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

BLADDER CANCER; BLADDER TUMOR ANTIGEN ASSAY; CANCER DIAGNOSIS; CANCER STAGING; DIAGNOSTIC ACCURACY; ENDOCYTOSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIGENETICS; FOOD AND DRUG ADMINISTRATION; GENE MUTATION; HEMATURIA; HUMAN; IMMUNOASSAY; KARYOMETRY; MICROSATELLITE MARKER; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTICYT NUCLEAR KARYOMETRY; REVIEW; TRANSITIONAL CELL CARCINOMA; URINALYSIS; URINE SEDIMENT;

CYSTOSCOPY; CYTODIAGNOSIS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL; URINALYSIS; URINARY BLADDER NEOPLASMS; URINE;

EID: 84867913960     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2012-200812     Document Type: Review

References (33)

1. Metts MC, Metts JC, Milito SJ, et al. Bladder cancer: a review of diagnosis and management. J Natl Med Assoc 2000;92:285-94.
2. Berger AP, Parson W, Stenzl A, et al. Microsatellite alterations in human bladder cancer: detection of tumor cells in urine sediment and tumor tissue. Eur Urol 2002;41:532-9.
3. http://www.aacc.org/SiteCollectionDocuments/NACB/LMPG/tumor/ chp3h-bladder.pdf (accessed 28 Feb 2012).
4. Tetu B. Diagnosis of urothelial carcinoma from urine. Mod Pathol 2009;22(Suppl 2):S53-9.
5. Tilki D, Burger M, Dalbagni G, et al. Urine markers for detection and surveillance of non-muscle-invasive bladder cancer. Eur Urol 2011;60:484-92.
6. Villicana P, Whiting B, Goodison S, et al. Urine-based assays for the detection of bladder cancer. Biomark Med 2009;3:265.
7. http://www.dako.com/08066-12may10-webchapter25.pdf (accessed 1 Feb 2012).
8. Arisan S. The importance of molecular tumor markers for bladder cancer. Turk J Canc 2003;33:171-6. (Pubitemid 38314025)
9. Vrooman OP, Witjes JA. Urinary markers in bladder cancer. Eur Urol 2008;53:909-16.
10. Bensalah K, Montorsi F, Shariat SF. Challenges of cancer biomarker profiling. Eur Urol 2007;52:1601-9. (Pubitemid 350052431)
11. Stenzl A, Feil G. Tumour markers in bladder cancer. Eur Oncol Dis 2006;1:73-6.
12. van Rhijn BW, van der Poel HG, van der Kwast TH. Cytology and Urinary Markers for the Diagnosis of Bladder Cancer. European Urology Supplements. 2009;8:536-41.
13. Cheng ZZ, Corey MJ, Parepalo M, et al. Complement factor H as a marker for detection of bladder cancer. Clin Chem 2005;51:856-63. (Pubitemid 40577922)
14. Shariat SF, Karam JA, Lotan Y, et al. Critical evaluation of urinary markers for bladder cancer detection and monitoring. Rev Urol 2008;10:120-35.
15. Guney S, Arisan S, Duman B, et al. Bladder tumor antigen sensitivity in bladder cancer patients. J Cell Mol Biol 2004;3:51-119.
16. van Rhijn BW, van der Poel HG, van der Kwast TH. Urine markers for bladder cancer surveillance: a systematic review. Eur Urol 2005;47:736-48.
17. Proctor I, Stoeber K, Williams GH. Biomarkers in bladder cancer. Histopathology 2010;57:1-13.
18. Van Tilborg AA, Bangma CH, Zwarthoff EC. Bladder cancer biomarkers and their role in surveillance and screening. Int J Urol 2009;16:23-30.
19. Mitra AP, Cote RJ. Molecular screening for bladder cancer: progress and potential. Nat Rev Urol 2010;7:11-20.
20. Bassi P, Marangi F, Volpe A, et al. Markers for urological malignancies. Eur Urol Rev 2010;5:36-43.
21. Lei Y, Yan S, Ming-De L, et al. Prognostic significance of Aurora-A expression in human bladder cancer. Acta Histochem 2011;113:514-18.
22. Tilki D, Singer BB, Shariat SF, et al. CEACAM1: a novel urinary marker for bladder cancer detection. Eur Urol 2010;57:648-54.
23. Kim YK, Kim WJ. Epigenetic markers as promising prognosticators for bladder cancer. Int J Urol 2009;16:17-22.
24. Kim WJ, Bae SC. Molecular biomarkers in urothelial bladder cancer. Cancer Sci 2008;99:646-52.
25. Phé V, Cussenot O, Rouprêt M. Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract. BJU Int 2009;104:896-901.
26. Shirodkar SP, Lokeshwar VB. Potential new urinary markers in the early detection of bladder cancer. Curr Opin Urol 2009;19:488-93.
27. Billerey C, Chopin D, Aubriot-Lorton MH, et al. Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors. Am J Pathol 2001;158:1955-9. (Pubitemid 32545179)
28. van Rhijn BW, Lurkin I, Radvanyi F, et al. The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate. Cancer Res 2001;61:1265-8. (Pubitemid 34292538)
29. Miyake M, Sugano K, Kawashima K, et al. Sensitive detection of FGFR3 mutations in bladder cancer and urine sediments by peptide nucleic acid-mediated real-time PCR clamping. Biochem Biophys Res Commun 2007;362:865-71. (Pubitemid 47390654)
30. Ohshima K, Inoue K, Fujiwara A, et al. Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One 2010;5:e13247.
31. Patel N, Sauter ER. Body fluid micro(mi)RNAs as biomarkers for human cancer. J Nucleic Acids Investig 2011;2:1-4.
32. Etheridge A, Lee I, Hood L, et al. Extracellular microRNA: a new source of biomarkers. Mutat Res 2011;717:85-90.
33. Bonner RB, Liebert M, Hurst RE, et al. Characterization of the DD23 tumor-associated antigen for bladder cancer detection and recurrence monitoring. Marker Network for Bladder Cancer. Cancer Epidemiol Biomark Prev 1996;5:971-8. (Pubitemid 26415869)